Literature DB >> 18644040

Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes.

E Cuenca-León1, R Corominas, N Fernàndez-Castillo, V Volpini, M Del Toro, M Roig, A Macaya, B Cormand.   

Abstract

Familial hemiplegic migraine (FHM) is a rare type of migraine with aura. Mutations in three genes have been described in FHM patients: CACNA1A (FHM1), ATP1A2 (FHM2) and SCN1A (FHM3). We screened 27 Spanish patients with hemiplegic migraine (HM), basilar-type migraine or childhood periodic syndromes (CPS) for mutations in these three genes. Two novel CACNA1A variants, p.Val581Met and p.Tyr1245Cys, and a previously annotated change, p.Cys1534Ser, were identified in individuals with HM, although they have not yet been proven to be pathogenic. Interestingly, p.Tyr1245Cys was detected in a patient displaying a changing, age-specific phenotype that began as benign paroxysmal torticollis of infancy, evolving into benign paroxysmal vertigo of childhood and later becoming HM. This is the first instance of a specific non-synonymous base change being described in a subject affected with CPS. The fact that the molecular screen identified non-synonymous changes in < 15% of our HM patients further stresses the genetic heterogeneity underlying the presumably monogenic forms of migraine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644040     DOI: 10.1111/j.1468-2982.2008.01645.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  18 in total

Review 1.  Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome.

Authors:  Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 2.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

Review 3.  Vestibular Migraine in Children and Adolescents.

Authors:  Thyra Langhagen; Mirjam N Landgraf; Doreen Huppert; Florian Heinen; Klaus Jahn
Journal:  Curr Pain Headache Rep       Date:  2016-12

4.  The hemiplegic migraine-associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition.

Authors:  Selma A Serra; Noèlia Fernàndez-Castillo; Alfons Macaya; Bru Cormand; Miguel A Valverde; José M Fernández-Fernández
Journal:  Pflugers Arch       Date:  2009-02-03       Impact factor: 3.657

5.  Williams syndrome with a "twist".

Authors:  Despoina Maritsi; Lydia Kossiva; George Vartzelis
Journal:  Case Rep Med       Date:  2010-06-16

Review 6.  Episodic Syndromes That May Be Associated With Migraine: A.K.A. "the Childhood Periodic Syndromes".

Authors:  Amy A Gelfand
Journal:  Headache       Date:  2015-08-03       Impact factor: 5.887

7.  Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred.

Authors:  Ester Cuenca-León; Roser Corominas; Magda Montfort; Josep Artigas; Manuel Roig; Mònica Bayés; Bru Cormand; Alfons Macaya
Journal:  Neurogenetics       Date:  2009-01-20       Impact factor: 2.660

8.  Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.

Authors:  Sanjeev Rajakulendran; Tracey D Graves; Robyn W Labrum; Dimitrios Kotzadimitriou; Louise Eunson; Mary B Davis; Rosalyn Davies; Nicholas W Wood; Dimitri M Kullmann; Michael G Hanna; Stephanie Schorge
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

Review 9.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

10.  Benign paroxysmal torticollis: phenotype, natural history, and quality of life.

Authors:  Kaitlin A Greene; Vivien Lu; Marta San Luciano; William Qubty; Samantha L Irwin; Barbara Grimes; Amy A Gelfand
Journal:  Pediatr Res       Date:  2021-02-09       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.